Long Term (>30 months following wound closure) assessments of cosmesis, function and quality of life in pediatric subjects following participation in study MW2012-01-01 evaluating the efficacy and safety of NexoBrid as compared to standard of care (SOC) treatment
Latest Information Update: 14 Nov 2023
At a glance
- Drugs Bromelains (Primary)
- Indications Burns; Wounds
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors MediWound
Most Recent Events
- 14 Nov 2023 Status changed from recruiting to completed.
- 14 Nov 2023 This trial has been completed(End Date: 01 Dec 2022), according to European Clinical Trials Database record.
- 28 Jul 2022 Status changed from not stated to recruiting.